Discontinuation of Memantine Standard Release and Its Impact on Patient Therapy

Author： Mondiello Taryn   Lam Sum  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.30, Iss.5, 2015-05, pp. : 283-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

By Kidwell Kelley M.   Harte Steven E.   Hayes Daniel F.   Storniolo Anna Maria   Carpenter Janet   Flockhart David A.   Stearns Vered   Clauw Daniel J.   Williams David A.   Henry N. Lynn  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2403-2411

Blackwell Publishing

Access to resources Recommend Favorite

Memantine: Its Role in Vascular Dementia

By  

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 449-456

Bentham Science Publishers

Access to resources Recommend Favorite

Donepezil/memantine: Myoclonus (first report with memantine) in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1163, 2007-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Memantine

By Jarvis B.   Figgitt D.P.  

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 465-476

Adis International

Access to resources Recommend Favorite

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

By Zemek Filip   Drtinova Lucie   Nepovimova Eugenie   Sepsova Vendula   Korabecny Jan   Klimes Jiri   Kuca Kamil  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 759-774

Informa Healthcare

Access to resources Recommend Favorite